Participated · Equity · Jul 2025

Synfini operates an AI Cloud Foundry platform that merges artificial intelligence, automated synthesis, and iterative molecular design to accelerate discovery and synthesis of small molecules. The platform integrates target selection, compound design, reaction route prediction, and synthesis into a single workflow that shortens iteration cycles and reduces costs. By combining physical and virtual chemistry, Synfini produces novel, optimized compounds more rapidly than traditional early discovery processes. Since spinning out from SRI in 2023, the company has confirmed its approach through early traction and strategic partnerships. Synfini will use recent funding to expand its software and automated lab capabilities, hire additional scientific and engineering staff, and deepen commercial partnerships. The company has raised a total of $53 million to date, including the latest $8.9 million expansion and a mix of venture investments and non-dilutive grants.

Participated · Seed · Nov 2022

Jurata Thin Film is a biotechnology company developing thin-film formulations that immobilize vaccines and biologics into a solid matrix to preserve therapeutic activity at room temperature for up to three years. The technology, originating in the lab of Maria Croyle at the University of Texas at Austin, is intended to simplify manufacturing, distribution, storage, and delivery of vaccines and biologics. Jurata’s films can be administered sublingually or buccally, or rehydrated for intramuscular injection, and the company is pursuing toxicity and regulatory testing for those routes. The company plans to use new funding to design and build a pilot-scale manufacturing line capable of fabricating over 1,000 doses per hour. Raised funds will also support additional R&D hires to support client evaluation projects and broaden the technology’s applicability. Jurata was founded in 2019 and is based in Houston, TX.